Our novel observations suggest that hyperglycaemia-induced STING activation contributes to aortic endothelial cell injury in diabetes, indicating that functional inhibition of STING may be a therapeutic strategy for diabetic vascular disease. This evidence concerns the gene STING1 and Hyperglycemia.